Clinical Trial: Immune Mechanisms and ECMO Strategies for Moderate-to-Severe ARDS

U.S., July 28 -- ClinicalTrials.gov registry received information related to the study (NCT07726940) titled 'Immune Mechanisms and ECMO Strategies for Moderate-to-Severe ARDS' on July 21.

Brief Summary: Acute respiratory distress syndrome (ARDS) poses a major threat to human health. Despite extracorporeal membrane oxygenation (ECMO) support, mortality among patients with ARDS remains high due to severe complications and suboptimal mechanical ventilation strategies. Elucidating the mechanisms underlying ECMO-related complications and lung injury repair, and establishing a precision intervention pathway covering the entire course of ECMO management, are urgent unmet needs for improving outcomes in ARDS patients and addressing major public he...